nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of responses to angiotensin II in the mouse
|
Bivalacqua, Trinity J |
|
2001 |
2 |
1_suppl |
p. S48-S53 |
artikel |
2 |
Angiotensin II blockade causes acute renal failure in eNOS-deficient mice
|
Schnermann, Jürgen |
|
2001 |
2 |
1_suppl |
p. S199-S203 |
artikel |
3 |
Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge
|
Allen, Andrew M |
|
2001 |
2 |
1_suppl |
p. S120-S124 |
artikel |
4 |
Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy
|
Lebeche, Djamel |
|
2001 |
2 |
1_suppl |
p. S154-S161 |
artikel |
5 |
Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress
|
Armando, Ines |
|
2001 |
2 |
1_suppl |
p. S130-S135 |
artikel |
6 |
Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
|
Casellas, Daniel |
|
2001 |
2 |
1_suppl |
p. S84-S90 |
artikel |
7 |
Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor
|
Jugdutt, Bodh I |
|
2001 |
2 |
1_suppl |
p. S162-S166 |
artikel |
8 |
Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries
|
Ytterberg, Hoa |
|
2001 |
2 |
1_suppl |
p. S37-S41 |
artikel |
9 |
Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction
|
van Rodijnen, William F |
|
2001 |
2 |
1_suppl |
p. S204-S210 |
artikel |
10 |
Development of salt-sensitive hypertension in a sensory denervated model: the underlying mechanisms
|
Wang, Donna H |
|
2001 |
2 |
1_suppl |
p. S125-S129 |
artikel |
11 |
Distinctions between non-peptide angiotensin II AT1-receptor antagonists
|
Vauquelin, Georges |
|
2001 |
2 |
1_suppl |
p. S24-S31 |
artikel |
12 |
Does protein binding modulate the effect of angiotensin II receptor antagonists?
|
Maillard, Marc P |
|
2001 |
2 |
1_suppl |
p. S54-S58 |
artikel |
13 |
Effects of low-dose candesartan on the rate of re-endothelialisation following vascular wound healing
|
Koshy, Prakash |
|
2001 |
2 |
1_suppl |
p. S81-S83 |
artikel |
14 |
Evidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries
|
Ytterberg, Hoa |
|
2001 |
2 |
1_suppl |
p. S42-S47 |
artikel |
15 |
Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells
|
Mehta, Jawahar L |
|
2001 |
2 |
1_suppl |
p. S70-S76 |
artikel |
16 |
Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?
|
Wagenaar, Lodewijk J |
|
2001 |
2 |
1_suppl |
p. S64-S69 |
artikel |
17 |
Improvements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats
|
Boffa, Jean-Jacques |
|
2001 |
2 |
1_suppl |
p. S211-S216 |
artikel |
18 |
Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
|
Skov, Karin |
|
2001 |
2 |
1_suppl |
p. S91-S94 |
artikel |
19 |
Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
|
Papademetriou, Vasilios |
|
2001 |
2 |
1_suppl |
p. S77-S80 |
artikel |
20 |
Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction
|
Abro, Emad |
|
2001 |
2 |
1_suppl |
p. S148-S153 |
artikel |
21 |
Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model
|
Griffin, Karen A |
|
2001 |
2 |
1_suppl |
p. S191-S195 |
artikel |
22 |
Reversal of cardiovascular remodelling with candesartan
|
Brown, Lindsay |
|
2001 |
2 |
1_suppl |
p. S141-S147 |
artikel |
23 |
Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion
|
Schulz, Rainer |
|
2001 |
2 |
1_suppl |
p. S136-S140 |
artikel |
24 |
Review: AT1-receptors in the central nervous system
|
Allen, Andrew M |
|
2001 |
2 |
1_suppl |
p. S95-S101 |
artikel |
25 |
Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
|
Morgan, Trefor |
|
2001 |
2 |
1_suppl |
p. S223-S226 |
artikel |
26 |
Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors
|
Coffman, Thomas M |
|
2001 |
2 |
1_suppl |
p. S10-S15 |
artikel |
27 |
Review: Interaction among angiotensin II, nitric oxide and oxidative stress
|
Zhou, Ming-Sheng |
|
2001 |
2 |
1_suppl |
p. S59-S63 |
artikel |
28 |
Review: Intrarenal angiotensin II levels in normal and hypertensive states
|
Navar, L Gabriel |
|
2001 |
2 |
1_suppl |
p. S176-S184 |
artikel |
29 |
Review: Lessons on renal function from transgenic mice lacking different angiotensin II receptors
|
Arendshorst, William J |
|
2001 |
2 |
1_suppl |
p. S167-S175 |
artikel |
30 |
Review: Promise of prevention and reversal of target organ involvement in hypertension
|
Frohlich, Edward D |
|
2001 |
2 |
1_suppl |
p. S4-S9 |
artikel |
31 |
Review: Role of angiotensin in central regulation of sympathetic activity: effect of dietary sodium chloride
|
DiBona, Gerald F |
|
2001 |
2 |
1_suppl |
p. S110-S113 |
artikel |
32 |
Review: Structural requirements for signalling and regulation of AT1-receptors
|
Hunyady, László |
|
2001 |
2 |
1_suppl |
p. S16-S23 |
artikel |
33 |
Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
|
Hollenberg, Norman K |
|
2001 |
2 |
1_suppl |
p. S185-S187 |
artikel |
34 |
Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia
|
Saavedra, Juan M |
|
2001 |
2 |
1_suppl |
p. S102-S109 |
artikel |
35 |
Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan
|
Vauquelin, Georges |
|
2001 |
2 |
1_suppl |
p. S32-S36 |
artikel |
36 |
The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion
|
Weinberg, Marc S |
|
2001 |
2 |
1_suppl |
p. S196-S198 |
artikel |
37 |
The renin-angiotensin system in obesity hypertension
|
Sharma, Arya M |
|
2001 |
2 |
1_suppl |
p. S114-S119 |
artikel |
38 |
The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
|
Weir, Matthew R |
|
2001 |
2 |
1_suppl |
p. S188-S190 |
artikel |
39 |
Use of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial
|
Weir, Matthew R |
|
2001 |
2 |
1_suppl |
p. S217-S222 |
artikel |